Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on October 2, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Esperovax

Awarded
BAA-20-100-SOL-0002Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-160
The Advanced Research Projects Agency for Health (ARPA-H) is seeking multiple awardees under Other Transaction Agreements for the Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) program. The objective is to develop a near real-time, non-destructive, AI-enabled system capable of screening pharmaceutical products and inputs through their packaging at ports of entry and other supply-chain nodes. By integrating multi-modal sensing, signal processing, and data fusion, the system aims to augment FDA oversight by detecting contamination, adulteration, and formulation variability without opening containers. The program is structured as a 54-month effort divided into three 18-month phases, culminating in a fieldable platform with integrated visual imaging and machine-readable code documentation. Eligible respondents include universities, non-profit organizations, small businesses, and other commercial entities, provided they maintain active registration in SAM.gov and are not entities of concern under the CHIPS and Science Act of 2022. The submission process requires a mandatory Solution Summary Presentation by September 21, 2026, followed by a full proposal due by November 10, 2026. Full proposals must include a technical and management plan, a task description document, a cost proposal narrative and workbook, and a milestone payment schedule. Selection will favor technologies capable of analyzing a broad range of products and packaging, while destructive testing methods and technologies requiring the opening of samples are explicitly excluded from the scope.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

about 7 hours ago

DEADLINE

in 20 days
NAICS: 541715
New
Federal
HYDROSPHERE, BIOSPHERE, & GEOPHYSICS (HBG) SUPPORT SERVICES II - FINAL REQUEST FOR PROPOSAL (FRFP)
Solicitation # 80GSFC27R0015
The National Aeronautics and Space Administration Goddard Space Flight Center is soliciting proposals for the Hydrosphere, Biosphere, and Geophysics (HBG) Support Services II contract, under solicitation number 80GSFC27R0015. This small business set-aside is a hybrid Indefinite Delivery Indefinite Quantity (IDIQ) contract with a five-year effective ordering period. The contract allows for the issuance of both Cost Plus Fixed Fee (CPFF) and Firm-Fixed Price (FFP) task orders to support science research and computing activities across various laboratories, including the Cryospheric Sciences, Ocean Ecology, Hydrological Sciences, Biospheric Sciences, Geodesy and Geophysics, and the Terrestrial Information Systems Laboratory. The primary objective is to develop and apply space, field-deployed, and laboratory-based technologies to address societal issues related to water resources, ecosystems, sea level change, and the Earth's magnetic and gravity fields. The scope of work encompasses scientific modeling, simulation, data assimilation, satellite instrument performance analysis, and the planning and execution of field campaigns. Performance will occur at the Goddard Space Flight Center and the contractor's facilities, with acceptance managed by the Contracting Officer or a designated representative. Award selection will be based on a tradeoff approach, prioritizing Mission Suitability as the most important factor, followed by Cost and Past Performance. Proposals must be submitted in four volumes, including a numerically scored Mission Suitability volume and a detailed Cost volume. Additionally, the contractor must adhere to strict security requirements, including the provision of a Cyber Supply Chain Risk Management plan and compliance with NDAA Section 889 regarding telecommunications and surveillance equipment.
NASA Goddard Space Flight Center

POSTED

about 7 hours ago

DEADLINE

in about 1 month
NAICS: 541715
New
Federal
Engineering Support for the Asymmetric Systems
Solicitation # N0017827R3106
Solicitation N0017827R3106 is a sources-sought effort for the Naval Surface Warfare Center Dahlgren Division to obtain comprehensive technical and engineering support for the Asymmetric Systems Division (H10). The anticipated contract will be a Cost-Plus-Fixed-Fee, Level of Effort Task Order with a five-year period of performance, consisting of a twelve-month base period and four twelve-month option periods. The primary objective is to provide qualified personnel to integrate advanced automation and asymmetric machine learning architectures into naval weapon systems across the entire acquisition lifecycle, from initial material solution analysis through testing and safe fielding. Work will be performed primarily at the Dahlgren, Virginia facility and at the contractor's own facilities. The scope of work is broad, encompassing multi-disciplinary engineering in domains such as software, mechanical, cyber, robotics, and RF micro-electronic design. Key deliverables include the development of data-driven validation frameworks, high-computing cloud services, and the implementation of Open Architecture standards. The contractor must adhere to strict security and quality requirements, including DFARS 252.204-7012 for system security plans and FAR 52.219-14 regarding subcontracting limitations. Award will be based on best value, evaluating technical capabilities, personnel qualifications and security clearances, and past performance as a prime contractor within the last five years. Invoicing will be managed through the Wide Area Workflow module on the Procurement Integrated Enterprise Environment system.
Nswc Dahlgren

POSTED

about 7 hours ago

DEADLINE

in 7 days

AI Contract Overview

Show more

The Easy Broad Agency Announcement BAA-20-100-SOL-0002, issued by the Division of Research, Innovation, and Ventures (DRIVe) within the Office of Biomedical Advanced Research and Development Authority (BARDA), seeks abstract submissions for transformative health security products and technologies. The program focuses on revolutionary innovations across various Areas of Interest (AOIs), with individual awards generally capped at a government share of less than 750,000 dollars. The solicitation is designed to be flexible, utilizing a series of Special Instructions to open, close, pause, or revise specific technical topics based on evolving public health needs. Key Areas of Interest have evolved to include a heavy emphasis on COVID-19 response, including molecular and point-of-care diagnostics, vaccines, and remote patient monitoring. Other critical focus areas include the ENACT program for early notification and treatment, solving sepsis, the ReDIRECT program for repurposing drugs against chemical threats, and the development of home-based diagnostics and digital health tools for pandemic preparedness. Additional specialized interests include the ImmuneChip+ platform, mitigating long-term effects of respiratory distress, and improving lung support for severe ARDS patients. Submissions are managed through the DRIVe portal, and the announcement remains open to all responsible sources.

General Info

Contract Value

$598,191

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

DC, USA

Set-Aside

NONE

Award Issued Date

Documents

22

BARDA EZ-BAA BAA-20-100-SOL-0002 Special Instructions 002

PDF, High priority: read this firstamendment
High

BARDA EZ-BAA BAA-20-100-SOL-0002 Special Instructions 006

PDF, High priority: read this firstamendment
High

BARDA EZ-BAA BAA-20-100-SOL-0002 Special Instructions 010

PDF, High priority: read this firstamendment
High

BARDA EZ-BAA BAA-20-100-SOL-0002 Special Instructions 020

PDF, High priority: read this firstamendment
High

DRIVE EZ-BAA (BAA-20-100-SOL-0002)

PDF, High priority: read this firstrfp
High

DRIVE EZ-BAA (BAA-20-100-SOL-0002) Amendment 001

PDF, High priority: read this firstamendment
High

DRIVe EZ-BAA Special Instructions 007 (BAA-20-100-SOL-0002)

PDF, High priority: read this firstamendment
High

DRIVe EZ-BAA Special Instructions 018 (BAA-20-100-SOL-0002)

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 001 - AOI #4: 2019-nCoV

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 003

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 004

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 005

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 008

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 009

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 011 - AOI #5 ReDIRECT

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 012

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 013: AOI #7 ImmuneChip+

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 014

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 015

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 016

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 017

PDF, High priority: read this firstamendment
High

EZ-BAA BAA-20-100-SOL-0002 Special Instructions 019

PDF, High priority: read this firstamendment
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

32 updates
PhaseAwarded
Posted

Solicitation

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed. The point of contact changed.

Notice updated

The notice description changed. The point of contact changed.

Notice updated

Response deadline changed from Feb 3, 2023 to Oct 18, 2022. The notice description changed.

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Aspr Administration For Strategic Preparedness And Response
Contacts2 people available
OfficeWashington, DC, 20201, USA
Office AddressWashington, DC, 20201, USA
Contacts
Troy Francis - Contracting Officer (Team Lead) DRIVe
Matthew McCord - Chief of Partnering DRIVe

Full Description

Show more
8/23/2021 - Please see Special Instructions 014 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 014, BARDA is announcing the following as part of its EZ-BAA (BAA-20-100-SOL-0002): Close Area of Interest (AOI) #1 supporting the Early Notification to Act, Control, and Treat (ENACT) program. Pause AOI #7 supporting the ImmuneChip+ program until further notice. Add AOIs #8 #9, #10, and #11a and #11b to the EZ-BAA: AOI #8: Bringing Laboratory Testing to the Home AOI #9: Digital Health Tools for Pandemic Preparedness AOI #10: Next Generation Sequencing (NGS)-based Agnostic Diagnostic for Respiratory RNA Virus Pathogens AOI #11a: Home-based, Over-the-Counter Diagnostics for the Detection of SARS-CoV-2 AOI #11b: Enabling Technologies to Support Home-Based Diagnostics for SARS-CoV-2 Acute Infection 3/4/2021 - Please see Special Instructions 013 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 013, BARDA is now accepting abstract submissions for "AOI #7: ImmuneChip+ as part of its EZ-BAA (BAA-20-100-SOL-0002). 10/22/2020 - Please see Special Instructions 012 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 012, BARDA is now accepting abstract submissions for "AOI #1: ENACT (Early Notification to Act, Control and Treat) and "AOI#2: Infection Severity & Solving Sepsis. Additionally, - AOI #4.3: Alternative Routes of Administration (AROA) for Vaccines is now - AOI #6: Beyond the Needle. 10/1/2020 - Please see Special Instructions 011 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 011, BARDA is now accepting abstract submissions for "Area of Interest #5: ReDIRECT (Repurposing Drugs In Response to Chemical Threats)" as part of its EZ-BAA (BAA-20-100-SOL-0002). 7/9/2020 - Please see Special Instructions 010 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 010, BARDA is adding topic #4.1-E under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002). 6/29/2020 - Please see Special Instructions 009 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 009, BARDA is revising topics #4.1-D and #4.3 immediately, and extending the closing date to 2359 HRS ET on 31 October 2020 under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002). 6/4/2020 - Amendment 001 to the EZ-BAA is now included as an attachment. Amendment 001 revises Section C of the EZ-BAA. Please also see Special Instructions 008 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 008, BARDA is revising topic #4.3 immediately, and closing topic #4.4 at 1700 HRS ET on 05 June 2020 under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002). 5/12/2020 - Please see Special Instructions 007 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 007, BARDA is closing topics #4.1-B and #4.1-C under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002). 4/27/2020 - Please see Special Instructions 006 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 006, BARDA is adding topic #4.1-D under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002). 4/2/2020 - Please see Special Instructions 005 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 005, BARDA is closing topic #4.1-A and revising topic #4.1-C under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002). 3/18/2020 - Please see Special Instructions 004 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 004, BARDA is closing topic #4.2 under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002). 3/9/2020 - Please see Special Instructions 003 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions, BARDA is adding several new topics under its temporary AOI #4: COVID-19 (renamed from 2019-nCoV) as part of its EZ-BAA (BAA-20-100-SOL-0002). 2/15/2020 - Please see Special Instructions 002 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions, BARDA is adding a new topic under its temporary AOI #4: 2019-nCoV as part of its EZ-BAA (BAA-20-100-SOL-0002). 2/3/2020 - Please see Special Instructions 001 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions, BARDA is temporarily suspending AOIs 1-3 as part of its EZ-BAA (BAA-20-100-SOL-0002), but is pleased to announce that it is now accepting abstract submissions for AOI #4: 2019-nCoV. 2/3/2020 - See attachment(s). This Easy Broad Agency Announcement (EZ-BAA) sets forth areas of interest (AOIs) for the Division of Research, Innovation, and Ventures (DRIVe) in the Office of Biomedical Advanced Research and Development Authority (BARDA), issued under paragraph 6.102(d)(2)(i) of the Federal Acquisition Regulation (FAR). Abstract submissions selected for award are considered to be the result of full and open competition and in full compliance with 41 U.S.C. - 3301.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS